Cargando…

Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer

Myeloid-derived suppressor cells (MDSC)s increase in blood and accumulate in the tumor microenvironment of tumor-bearing animals, contributing to immune suppression in cancer. Silibinin, a natural flavonoid from the seeds of milk thistle, has been developed as an anti-inflammatory agent and supporti...

Descripción completa

Detalles Bibliográficos
Autores principales: Forghani, Parvin, Khorramizadeh, Mohammad R, Waller, Edmund K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987072/
https://www.ncbi.nlm.nih.gov/pubmed/24574320
http://dx.doi.org/10.1002/cam4.186
_version_ 1782311827428868096
author Forghani, Parvin
Khorramizadeh, Mohammad R
Waller, Edmund K
author_facet Forghani, Parvin
Khorramizadeh, Mohammad R
Waller, Edmund K
author_sort Forghani, Parvin
collection PubMed
description Myeloid-derived suppressor cells (MDSC)s increase in blood and accumulate in the tumor microenvironment of tumor-bearing animals, contributing to immune suppression in cancer. Silibinin, a natural flavonoid from the seeds of milk thistle, has been developed as an anti-inflammatory agent and supportive care agent to reduce the toxicity of cancer chemotherapy. The goals of this study were to evaluate the effect of silibinin on MDSCs in tumor-bearing mice and antitumor activity of silibinin in a mouse model of breast cancer. 4T1 luciferase-transfected mammary carcinoma cells were injected into in the mammary fat pad female BALB/c mice, and female CB17-Prkdc Scid/J mice. Silibinin treatment started on day 4 or day 14 after tumor inoculation continued every other day. Tumor growth was monitored by bioluminescent imaging (BLI) measuring total photon flux. Flow cytometry measured total leukocytes, CD11b(+) Gr-1(+) MDSC, and T cells in the blood and tumors of tumor-bearing mice. The effects of silibinin on 4T1 cell viability in vitro were measured by BLI. Treatment with silibinin increased overall survival in mice harboring tumors derived from the 4T1-luciferase breast cancer cell line, and reduced tumor volumes and numbers of CD11b(+)Gr-1(+) MDSCs in the blood and tumor, and increased the content of T cells in the tumor microenvironment. Silibinin failed to inhibit tumor growth in immunocompromised severe combined immunodeficiency mice, supporting the hypothesis that anticancer effect of silibinin is immune-mediated. The antitumor activity of silibinin requires an intact host immune system and is associated with decreased accumulation of blood and tumor-associated MDSCs.
format Online
Article
Text
id pubmed-3987072
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher John Wiley & Sons Ltd
record_format MEDLINE/PubMed
spelling pubmed-39870722014-04-22 Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer Forghani, Parvin Khorramizadeh, Mohammad R Waller, Edmund K Cancer Med Original Research Myeloid-derived suppressor cells (MDSC)s increase in blood and accumulate in the tumor microenvironment of tumor-bearing animals, contributing to immune suppression in cancer. Silibinin, a natural flavonoid from the seeds of milk thistle, has been developed as an anti-inflammatory agent and supportive care agent to reduce the toxicity of cancer chemotherapy. The goals of this study were to evaluate the effect of silibinin on MDSCs in tumor-bearing mice and antitumor activity of silibinin in a mouse model of breast cancer. 4T1 luciferase-transfected mammary carcinoma cells were injected into in the mammary fat pad female BALB/c mice, and female CB17-Prkdc Scid/J mice. Silibinin treatment started on day 4 or day 14 after tumor inoculation continued every other day. Tumor growth was monitored by bioluminescent imaging (BLI) measuring total photon flux. Flow cytometry measured total leukocytes, CD11b(+) Gr-1(+) MDSC, and T cells in the blood and tumors of tumor-bearing mice. The effects of silibinin on 4T1 cell viability in vitro were measured by BLI. Treatment with silibinin increased overall survival in mice harboring tumors derived from the 4T1-luciferase breast cancer cell line, and reduced tumor volumes and numbers of CD11b(+)Gr-1(+) MDSCs in the blood and tumor, and increased the content of T cells in the tumor microenvironment. Silibinin failed to inhibit tumor growth in immunocompromised severe combined immunodeficiency mice, supporting the hypothesis that anticancer effect of silibinin is immune-mediated. The antitumor activity of silibinin requires an intact host immune system and is associated with decreased accumulation of blood and tumor-associated MDSCs. John Wiley & Sons Ltd 2014-04 2014-01-20 /pmc/articles/PMC3987072/ /pubmed/24574320 http://dx.doi.org/10.1002/cam4.186 Text en © 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Forghani, Parvin
Khorramizadeh, Mohammad R
Waller, Edmund K
Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
title Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
title_full Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
title_fullStr Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
title_full_unstemmed Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
title_short Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
title_sort silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987072/
https://www.ncbi.nlm.nih.gov/pubmed/24574320
http://dx.doi.org/10.1002/cam4.186
work_keys_str_mv AT forghaniparvin silibinininhibitsaccumulationofmyeloidderivedsuppressorcellsandtumorgrowthofmurinebreastcancer
AT khorramizadehmohammadr silibinininhibitsaccumulationofmyeloidderivedsuppressorcellsandtumorgrowthofmurinebreastcancer
AT walleredmundk silibinininhibitsaccumulationofmyeloidderivedsuppressorcellsandtumorgrowthofmurinebreastcancer